International Clinical Trial: Skin Safety test of Shining Powder

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117402) titled 'Skin Safety test of Shining Powder' on Sept. 10.

Study Type: Interventional

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: N.Ranga Roa and Sons Private Limited

Intervention: Intervention1: Finn chamber: Each patch contains 0.04mg/(40 microliter), of 1.Shining Powder, 2.Negative control (0.9 Percent NaCl), 3.Positive Control- (1 Percent SLS) Route of Administration: Topical Frequency: Once Duration:24hrs Control Intervention1: Not Applicable: Not Applicable

Recr...